There's one big difference though - Pfizer is seeking a green light for second booster dose of Comirnaty for people aged 60 and over and those in high-risk groups, while Moderna is going for a ...

Learn More » Moderna is recognized as a pioneer in messenger RNA (mRNA ... Shifting sentiment about the need for annual booster vaccination, competition from alternative therapeutics, and the ...

Moderna's chief executive. He stressed however that the mRNA-1273.214 candidate – which combines the current SpikeVax booster with an Omicron-specific candidate – is the company's lead ...

A preprint study posted late last week on the server medRxiv reveals that the current Moderna COVID-19 vaccine is 53% ...

A protein-based booster vaccine made by Novavax, which works differently to the Pfizer and Moderna jabs, is also available. Moderna hopes to launch a combined flu and Covid vaccine later in 2025 ...

(Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug Administration's top ...

(Reuters) -Shares of U.S. biotech companies fell as much as 10% premarket on Monday following reports that a top vaccine ...

Shares in Moderna and Novavax fell Monday, following a Wall Street Journal report that the Food and Drug Administration’s top vaccine official has been pushed out. Shares in some larger ...

People aged 80 years of age and over, along with other at-risk groups, are being offered a Spring Covid-19 booster vaccine ...

The NHS spring booster campaign is offering Covid jab to groups of vulnerable patients across the UK. Around 7.5 million ...

Learn More » Moderna is recognized as a pioneer in messenger ... Shifting sentiment about the need for annual booster vaccination, competition from alternative therapeutics, and the withdrawal ...